Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
<tr> | <tr> | ||
<td style="width:25%; vertical-align:top;border-width:1px;"> | <td style="width:25%; vertical-align:top;border-width:1px;"> | ||
| + | =====Anti-CD20 [[Monoclonal Antibody]]===== | ||
| + | * Bexxar - Generic: Tositumomab | ||
| + | * Arzerra - Generic: Ofatumumab | ||
| + | * Rituxan - Generic: Rituximab | ||
| + | * Zevalin - Generic: Ibritumomab | ||
=====[[EGFR]] Inhibitor===== | =====[[EGFR]] Inhibitor===== | ||
* Herceptin - Generic: Trastuzumab | * Herceptin - Generic: Trastuzumab | ||
Revision as of 09:35, 1 December 2010
Anti-CD20 Monoclonal Antibody
EGFR InhibitorVEGF Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
